Waiv: Funding, Investors & Team (Sep 2026)
Waiv is a French-American startup that uses artificial intelligence to find the right treatment for every patient. Our focus is to use AI to discover and develop better treatments for unmet medical needs, starting with the fight against cancer. They use AI to identify new drug candidates, de-risk and accelerate clinical trials and build diagnostic tools that improve patient outcomes. Using federated learning, a pioneering collaborative AI framework, Owkin enables medical and biopharma partners to unlock valuable insights from siloed datasets, while protecting patient privacy and securing proprietary data. Owkin was co-founded by Thomas Clozel MD, a clinical research doctor and former assistant professor in clinical onco-hematology, and Gilles Wainrib, a pioneer in the field of machine learning in biology, in 2016. Owkin has raised over $255 million and became a ‘unicorn’ – a startup valued at more than $1 billion – in November 2021 through a $180 million investment from French biopharma company Sanofi.
Waiv has raised $33.0M across 1 funding round on record, the most recent an undisclosed round of $33.0M announced in Mar 2026.
That round is above the $5.5M median round size for Artificial Intelligence companies tracked on FundedIQ over the last two years.
Waiv Company Profile and Key Stats
Latest funding round on record: Mar 2026.
Waiv Funding Rounds
Waiv Founders and Leadership Team
Contact details for the Waiv team: 1 has a LinkedIn profile.
Start 14-day free trial →Waiv Funding Compared to Other Artificial Intelligence Startups
Waiv's latest round of $33.0M is above the median round in Artificial Intelligence. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Waiv in Artificial Intelligence and New York
Companies Similar to Waiv
Socure is a predictive analytics platform for digital identity verification of consumers. Socure's predictive…
Instinct is an artificial intelligence startup developing AI technology.
Significant gives vehicle-mounted PC vision innovation that distinguishes visual deformities in network…
Cloverleaf AI exists to help you fill your pipeline with high-quality SLED leads. Tell us what you deliver,…
Emerald AI develops software and platforms that manage and coordinate energy use for artificial intelligence…
Gatik, a new company, is creating technology for self-driving trucks that are used for short-distance…
Generalist AI develops AI and robotics technologies focused on enabling robots to perform physical tasks in…
Quintessent is a start-up in Santa Barbara that specializes in bringing quantum dot-based lasers and photonic…
Contact: Cardiosense is building a physiological waveform data platform that leverages novel multi-modal…
Thunder is a Cloud computing to democratize access to GPUs and solve the ongoing GPU shortage. Decentralized…
Deepgram helps enterprises unlock the potential of their audio data with custom trained speech recognition…
Waiv Funding FAQs
What does Waiv do?
Waiv is a French-American startup that uses artificial intelligence to find the right treatment for every patient. Our focus is to use AI to discover and develop better treatments for unmet medical needs, starting with the fight against cancer. They use AI to identify new drug candidates, de-risk and accelerate clinical trials and build diagnostic tools that improve patient outcomes. Using federated learning, a pioneering collaborative AI framework, Owkin enables medical and biopharma partners to unlock valuable insights from siloed datasets, while protecting patient privacy and securing proprietary data. Owkin was co-founded by Thomas Clozel MD, a clinical research doctor and former assistant professor in clinical onco-hematology, and Gilles Wainrib, a pioneer in the field of machine learning in biology, in 2016. Owkin has raised over $255 million and became a ‘unicorn’ – a startup valued at more than $1 billion – in November 2021 through a $180 million investment from French biopharma company Sanofi.
How much funding has Waiv raised?
Waiv has raised $33.0M across 1 round on record. The most recent is an undisclosed round of $33.0M announced in Mar 2026.
When did Waiv last raise funding?
Waiv's most recent funding round on record is an undisclosed round of $33.0M, announced in Mar 2026.
Who founded Waiv?
FundedIQ lists Magnus Berggren (Founder) at Waiv.
Where is Waiv headquartered?
Waiv is based in New York, New York, United States.
How many employees does Waiv have?
Waiv is in the 251-500 employee band.
How does Waiv's funding compare to other Artificial Intelligence startups?
Waiv's latest round of $33.0M is above the $5.5M median round size for Artificial Intelligence companies on FundedIQ across 7,233 tracked companies over the last two years.
About FundedIQ's Waiv Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Waiv is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.